| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  M2I Life Sciences Leader in Integrated pest management; Expert in Biocontrol & Pheromones #nopesticides Molecule Custom Synthesis #CDMO M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological crop protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant. M2I holds a portfolio of … Type: | 38 | 8 | 29 | 135 |
 | MaaT Pharma The leading microbiome company in oncology MaaT Pharma has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes in life-threatening diseases. Committed to treating blood cancers and graft-versus-host disease, a serious complication of allogeneic stem cell transplantation, MaaT Pharma has already achieved proof of concept in acute myeloid leukemia patients. Supporting the further expansion of our pipeline into larger indications, we have built a powerful discovery and analysis platform to evaluate drug candidates, determine novel disease targets and identify biomarkers for microbiome-related conditions. Our therapeutics are produced through a standardized cGMP manufacturing and quality control process … Type: | 25 | 8 | 21 | 76 |
 | Nando Biotechnology company that develops and manufactures high-added-value microbiological and chemical products "Nando" is a biotechnology company that develops and manufactures high-added-value microbiological products and chemical additives for agriculture and industry. Through innovation, combining scientific advances in biotechnology, chemistry and engineering, the company develops and markets biostimulants, surfactants and chemical products for use in crop and livestock production and in various industries. With one of the largest R&D (research and experimental development) centers in Northern Europe, and in collaboration with research centers and universities worldwide, “Nando“ has developed a portfolio of over 50 specialized products Formulation Chemistry, Manufacturing, Agro Chemicals, Biostimulants, … Type: | 25 | 8 | 4 | 120 |
 | Ginkgo Bioworks, Inc. Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our … Type: | 12 | 8 | 1 | 10 |
 | GAIAGO We believe that Mankind thrives when Soils thrive. We aim to become world leader in Soils revitalization 🚀#hiring 🚀 GAIAGO is an Agtech company based in the region of St Malo, France. Only healthy Soils allow abundant and quality food production. We produce a new generation of Soil improvements tools, effective for all agricultures. We contribute to the farmer’s mission: cultivate and transmit a healthy and fertile Soil AgTech, Biotechnology, Agronomy, and Soil Tags: FrenchTech2030 Type: | 22 | 8 | 16 | 65 |
 |  Amolyt Pharma Advancing peptides for the treatment of rare endocrine and related diseases Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors. Hypoparathyroidism, Endocrinology, Metabolic Disease, Therapeutic Peptides, … Tags: FrenchTech2030 Type: | 9 | 8 | 1 | 62 |
 | InSiliBio We use innovating solutions to test molecules through original bioinformatic methods. Our proposed methods are fully eth InSiliBio is a revolutionary contract research organization (CRO). We use innovating solutions to test molecules through original bioinformatic methods. Within the perspective of developing novel products and formulations, cosmetic, pharmaceutic and food companies undertake long research (up to several years), with expensive investments. These experiments often provide only fragmented information. These trials are sometimes being conducted on living organisms (animals, human cell etc. ), which are increasingly questioned from an ethical standpoint. Our proposed methods are fully ethical, fast, reliable and cost-effective. Our … Type: | 15 | 8 | 9 | 7 |
 | AIHERD The Intelligent System that Cares for You and Your Animals 🐮🚀💚 🚀 Welcome to the world of AIHERD, the Nantes gem that will ignite your farmer's heart with a bold and innovative vision! 💡🐮 At AIHERD, we've gathered the brightest minds in the field: a dynamic team of passionate veterinarians, AI geniuses, and outstanding management specialists, all working in close collaboration with the prestigious CEA. Together, we form an explosive cocktail to revolutionize agriculture and pamper our adorable four-legged cows! 🌾💚 Our secret? Real-time visual analysis of bovine farms, powered by our cutting-edge artificial intelligence algorithms! 🐄💻 Imagine a world … Type: | 41 | 8 | 19 | 15 |
 | Biomemory Biomemory provides biodigital data storage for large companies and administrations. Biomemory creates DNA Drives for large corporates and administrations. We organize and store data on biocompatible DNA molecules. Type: | 18 | 8 | 10 | 18 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 17 | 8 | 12 | 10 |
 | ADLIN Science Your digital partner in Life Science innovation ADLIN Science assists researchers in the management, analysis and valorization of multi-omics data. By providing a software to facilitate the generation of quality and interoperable data, ADLIN Science enables researchers to gain in scientific efficiency, to save time and to valorize economically and scientifically their data. ADLIN Science solution is based on a technical infrastructure co-developed with academic research allowing biologists, bioinformaticians and mathematicians to work within multi-disciplinary teams responding to a specific biological question. Health-tech, Logiciel, Multi-omic, Data, Société à mission, Médecine de précision, Data structuration, Data analysis, IA, Data visualization, Biostatistic, … Type: | 36 | 8 | 31 | 30 |
 | Redberry SAS Industrial microbiology testing providing immediate results at performance and ease-of-use never reached before. Redberry develops a new platform aimed at avoiding the culture phase of microorganisms in industrial microbiology and thus providing immediate results at cost, performance and ease-of-use never reached before. Microbiology and Diagnostics Type: | 18 | 8 | 15 | 14 |
 | epilab A screening point-of-care test for Tuberculosis : an unmet need to eradicate tuberculosis epilab's screening test helps health organization who wants to fight tuberculosis by bridging the diagnosis gap in developing countries and downscaling tuberculosis infections and victims. Type: | 10 | 8 | 2 | 5 |
 | Acticor Biotech To treat the acute phase of ischemic stroke ! Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for a safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes. Acticor Biotech’s project stems from the sheer need for new therapeutic options to manage stroke. According to the World Health Organization, 15 million people suffer stroke worldwide each year. Of these, 5 million die and another 5 million are permanently disabled. Stroke is the third cause of death in the … Type: | 10 | 9 | 4 | 36 |
 | Biocat, BioRegion of Catalonia Doing now what the BioRegion of Catalonia needs next Biocat is the institution that promotes the life sciences and healthcare ecosystem in Catalonia and works to maximize its economic and social impact. Biocat’s strategy focuses on positioning the BioRegion of Catalonia as one of the leading European hubs, offering researchers and professionals innovative capacity with programs to improve talent and entrepreneurship, accelerating technology transfer and business growth by supporting TTOs and startups, and helping attract investors and investment to the ecosystem. Created in 2006 by the Government of Catalonia and the Barcelona City Council, Biocat also promotes far-reaching political strategies … Type: | 41 | 9 | 38 | 40 |
 | MabDesign The Biotherapy Network MabDesign is a unique membership organization that aims to structure, mobilize and support the development of the French industrial sector in the field of biotherapy. MabDesign is strategically located in Lyon, at the heart of Europe. Our Mission: - Structure the French industrial sector working in the field of biotherapy; - Support companies' development & competitiveness; - Contribute to the development and production of biomolecules in France. For more information please contact us at : contact@mabdesign.fr Therapeutic antibody, Immunotherapy, biotechnology, Networking, Innovation, Training, Business Development, Cell Therapy, Gene Therapy, CAR T Cells, biotherapy, biomanufacturing, ATMPs, vaccines, Events, … Type: | 37 | 9 | 32 | 27 |
 | BIOKET Bioeconomy Key Enabling Technologies platform Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Trois-Rivières (QC), Canada -- May 23th-25th, 2023 -- Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, … Type: | 28 | 9 | 22 | 2 |
 | Valneva Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya Valneva is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our deep expertise across multiple vaccine modalities, focused on providing either first-, best- or only-in-class vaccine solutions. We have a strong track record, having advanced multiple vaccines from early R&D to approvals, and currently market three proprietary travel vaccines, including the world’s first and only chikungunya vaccine, as well as certain third-party vaccines. … Type: | 22 | 9 | 5 | 623 |
 | Mablink Bioscience Transforming cancer immunotherapy with next generation ADCs Mablink Bioscience is a French biotechnology company that is actively involved in the fight against cancer by bringing disruptive therapeutic solutions. With its Antibody-Drug Conjugates (ADC) masking technology, Mablink Bioscience aims to dramatically improve the efficiency of ADC therapies and accelerate the development of new treatments. Based in Lyon, where it is developing an unprecedented innovation center, Mablink currently has around 30 employees with diverse backgrounds. biotechnology, drug development, drug discovery, oncology, and R&D Type: | 15 | 9 | 10 | 35 |
 | GREEN IMPULSE [Automatic translation follows] Value, protect, nourish Green Impulse is a French start-up which develops new biocontrol solutions for agriculture and is committed to reducing the use of pesticides. Tags: FrenchTech2030 Type: | 20 | 9 | 11 | 16 |
 |  Amiroy [Automatic translation follows] Innovative Biomaterials AMIROY develops environmentally friendly solutions derived from biological sources to support agricultural production. AMIROY has developed a patented technology thanks to which it is today it is possible to fuse natural polymers such as polypeptides with materials organic and trace elements, to create tailor-made biostimulants adapted to each type of plant. These biostimulants greatly outperform conventional biostimulants in terms of effectiveness, and they also resist washing. Organic Agriculture, Biotechnology, and Biomaterials Type: | 11 | 9 | 9 | 2 |
 | NETRI INNERVATE. SCREEN. PREDICT. NETRI is a technology enabling company that provides human cell based smart assays for high throughput preclinical data acquisition for the neurological Pharma & Cosmetics industries. We provide organs-on-chip solutions & interoperable in vitro models designed to deeply accelerate drug discovery and preclinical trials by mimicking in vivo neural connectivity. neuroscience, microfluidics, neural network, organ on chip, neurofluidics, neurological troubles, Alzheimer, Parkinson, organonchip, dermo-cosmetics, and toxicology Type: | 28 | 9 | 23 | 39 |
 | Nosopharm Nosopharm is an innovative biotechnology company headquartered in Lyon (France) and specialized in the research and development of new molecules to combat antimicrobial resistance (AMR). The mission of Nosopharm is to discover and develop novel first-in-class anti-infectives addressing unmet medical needs. The innovative anti-infective drug discovery platform developed by Nosopharm is based on the therapeutic exploitation of a very original bioresource: the bacterial genera Xenorhabdus and Photorhabdus. Anti-Infectives, Drug Discovery, Antibiotics, and Microbiology Type: | 12 | 10 | 2 | 7 |
 | Pherecydes Pharma At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of … Type: | 13 | 10 | 4 | 13 |
 | Pili carbon conscious color company Pili, carbon conscious color company Pili is the leader in bio-based colorants and pigments. Its unique fermentation and sustainable chemistry processes, enable the production of high-performance, and low-carbon colors. Its technology aims at decarbonizing the color industry by drastically reducing the use of chemicals and fossil resources, particularly oil. Its products are designed for the textile, inks, paints & coatings and plastics sectors. Founded in 2015, Pili operates from 3 different sites: Toulouse White Biotechnology (TWB), Paris and the Roches-Roussillon industrial platform in Isère. With around 40 employees to date, the company has invested over €35 … Type: | 17 | 10 | 8 | 52 |
 | SOPHiA GENETICS Democratizing Data-Driven Medicine, Together! SOPHiA GENETICS is the creator of SOPHiA DDMTM, a cloud-based platform capable of analyzing data and generating insights from complex multimodal data sets and different modalities. The SOPHiA DDMTM Platform enables healthcare institutions to get quick, robust insights from their data. We apply our technology to areas such as cancer and inherited disorders, where combining genomic and phenotypic information is vital to support research and drug development efforts. SOPHiA GENETICS' data-sharing methodology also helps researchers and healthcare professionals work together as a community by sharing and leveraging patterns identified via artificial intelligence and machine learning. Our … Type: | 23 | 10 | 11 | 484 |
 | Transgene Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer. | 20 | 10 | 9 | 211 |
 | Neoplants The first generation of plants bioengineered to fight air pollution. www.neoplants.com The first plant-microbiome systems bioengineered to purify indoor air. | 15 | 10 | 8 | 36 |
 | ELICIT PLANT The only efficient Bio-Intrant to fight Water Stress ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, … Tags: FrenchTech2030 Type: | 18 | 10 | 11 | 75 |
 | StemInov Births can save lives StemInov is a French Drug Discovery company working on a innovative cell based therapy in immunology Type: | 13 | 10 | 1 | 4 |
 | Veragrow [Automatic translation follows] The efficiency of nature 📍Company based in Normandy 🌱 Producer of biostimulants based on vermicompost ♻️ Valorization of biowaste by continuous flow vermicomposting 350 million years! It is over this time that earthworms have crossed the ages and natural selection by fertilizing the soil in a virtuous circle of continuous enrichment. VERAGROW has managed to concentrate these agronomic virtues in liquid biostimulants based on vermicompost and ingredients of 100% natural origin. They improve the absorption of nutrients and resistance to abiotic stress by the plant, thus optimizing the use of agricultural inputs. All of these effects have … Type: | 33 | 11 | 21 | 20 |
 | Osivax Pioneering A New Class of Universal Vaccines Osivax is a clinical-stage biopharmaceutical company leveraging its novel, self-assembling nanoparticle platform technology, oligoDOM®, to develop transformative, first-in-class pan-respiratory virus vaccines generating superior T-cell responses in addition to strong and sustained B-cell responses. The company is establishing proof of concept with its broad-spectrum, “universal” influenza candidate, OVX836, which is currently in Phase 2 clinical trials with over 1200 subjects tested and encouraging efficacy proof of concept data. Osivax’ ambition is to develop a pan-respiratory virus vaccine to prevent all strains of influenza and all variants of sarbecovirus in one single shot. The company … Tags: FrenchTech2030 Type: | 22 | 11 | 13 | 53 |
 | Onima Creating super-ingredients from brewer's yeast, leveraging the power of upcycling to build the foods of tomorrow. From Waste ___ to Wonder We strive to reveal the treasures in what others deem obsolete ✨ Onima is committed to creating more resilient ways of production at the heart of our food systems by unlocking all the potential of upcycled goods. Our journey started with the production of a super-ingredient obtained from upcycled brewer’s yeast through a unique debittering process 🍻 Type: | 15 | 11 | 7 | 26 |
 | Owkin We use AI to find the right treatment for every patient. Owkin is an AI biotechnology company that uses AI to find the right treatment for every patient. We combine the best of human and artificial intelligence to answer the research questions shared by biopharma and academic researchers. By closing the translational gap between complex biology and new treatments, we bring new diagnostics and drugs to patients sooner. We use AI to identify new treatments, de-risk and accelerate clinical trials and build diagnostic tools. Using federated learning, a pioneering collaborative AI framework, Owkin enables partners to unlock valuable insights from … Type: | 32 | 12 | 22 | 438 |
 | myBrain Technologies Use our brain analysis platform to develop better products and services La plateforme de myBrain Tech aide les industries à simplifier l'interprétation de la dynamique du cerveau et à extraire des informations instructives pour mieux comprendre l'impact de leur produit ou service sur le cerveau de leurs utilisateurs. Notre équipe de neuroscientifiques et de data scientists développe des algorithmes et des tableaux de bord automatisés pour analyser et interpréter les données EEG et comportementales des humains dans un contexte réel, et créer un modèle d'IA stratégique. myBrain Tech's platform helps industries to simplify the interpretation of brain dynamics and to … Type: | 24 | 12 | 13 | 14 |
 | DNA Script Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology Tags: FrenchTech120 FrenchTech2030 Type: | 31 | 12 | 22 | 205 |
 | Biotechnology Innovation Organization BIO, Where breakthroughs begin BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. Our mission is to be the champion of biotechnology and the advocate for our member organizations—both large and small. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. We also represent state and regional biotech associations, service providers to the industry and academic centers. biotech, association, life sciences, biofuels, gmo, cures, energy, agriculture, … Type: | 34 | 12 | 19 | 704 |
 | EVerZom Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this … Type: | 12 | 12 | 0 | 18 |
 | Smart Immune Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T … Type: | 21 | 12 | 11 | 40 |
 | Valbiotis Valbiotis is a commercially oriented Research & Development company committed to scientific innovation for preventing and combating metabolic and cardiovascular diseases in response to unmet medical needs. Valbiotis has adopted an innovative approach by developing a new class of health nutrition products designed to reduce the risk of major metabolic and cardiovascular diseases, relying on a multi-target strategy enabled by the use of plant-based terrestrial and marine resources. Created at the beginning of 2014 in La Rochelle, the Company has established three sites in France – Périgny, La Rochelle (17) and Riom (63) – and a subsidiary in Quebec City … Type: | 23 | 13 | 13 | 62 |
 | TreeFrog Therapeutics Cell Therapy for All TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological … Tags: FrenchTech120 FrenchTech2030 Type: | 35 | 13 | 26 | 137 |
 | ImCheck Therapeutics Bringing a novel class of Butyrophilin-targeted checkpoint modulators into the clinic ImCheck Therapeutics is designing and developing a new generation of immunotherapeutic antibodies targeting butyrophilins, a novel super-family of immunomodulators. As demonstrated by lead clinical-stage program ICT01, which has a mechanism of action to simultaneously modulate innate and adaptive immunity, ImCheck's “first-in-class” activating antibodies may be able to produce superior clinical results as compared to the first-generation of immune checkpoint inhibitors and, when used in combination, to overcome resistance to this group of agents. In addition, ImCheck’s antagonist antibodies are being evaluated as potential treatments for a range of autoimmune … Tags: FrenchTech120 FrenchTech2030 Type: | 28 | 13 | 18 | 51 |
 | Bioteos [Automatic translation follows] Act today, protect tomorrow Concerned about current environmental and health issues 🌍, Bioteos aims to combine nature and technology in the service of Humans. 🤝 We therefore developed OXYLON, a carbon sink based on the immense potential of microalgae in order to purify ambient air. 🧪 Type: | 34 | 13 | 24 | 10 |
 | Eranova Transforming green algae into bio-based resins. Thanks to an innovative and patented solution, our company provides an answer to these two global problems. Our technology uses green macro algae stranded on beaches, a pollutant, as a resource for the production of bio-based, recyclable, compostable resins. This is called Upcycling. Type: | 36 | 13 | 25 | 14 |
 | CARBIOS Biotechnology powering plastic and textile circularity Carbios SA is a green chemistry company that focuses on discovering and developing enzymatic bioprocesses applied to plastic and textile polymers. The Company creates a new generation of fully biodegradable plastics with a controlled lifespan, a process enabling infinite biorecycling of plastic waste (PET) and a new biological pathway for the production of competitive biosourced polymers. Bioplasturgie, Biodégradation, Biorecyclage, Economie circulaire, Innovation, and Enzymes Type: | 42 | 15 | 28 | 141 |
 | WhiteLab Genomics AI/ML for Genomic Therapies We are specialised in AI solutions for advanced therapies such as gene and cell therapies. Tags: FrenchTech2030 Type: | 38 | 15 | 28 | 38 |
 | inalve Feeding the world sustainably, without compromise on Productivity, Environment, Naturalness & Health. In algae veritas Building a sustainable future together. Microalgae are able to propose solutions to many challenges of the positive economy. We cultivate them for various applications and animal nutrition in particular. Feed, Protéines végétales, Agro-industrie, sustainability , innovation, aquaculture, nutraceutic, biotechnology, microalgae, ingredients, nutrition, and health Type: | 29 | 16 | 19 | 18 |
 | ALLIS-NA | Alliance Innovation Santé Nouvelle-Aquitaine [Automatic translation follows] Let's facilitate the emergence of health solutions together The Health Innovation Alliance, ALLIS-NA, aims to bring together all industrial, academic, institutional and hospital forces around common values for the benefit of patients. Our missions: Represent and Lead the Health Ecosystem in New Aquitaine to support its economic and territorial development: - Be a “partner” for HEALTH innovation professionals - Facilitate connections and alliances - Promote and represent professionals in the sector - Accelerate value creation and business growth Do not hesitate to contact us and join the network! Health, Biotechnology, Medtech, Medical devices, Pharma, life sciences, Healthcare … Type: | 36 | 16 | 0 | 8 |
 | BioNTech SE Our vision is to harness the power of the immune system to develop novel therapies against cancer & infectious diseases. At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized. To pioneer the next generation of patient-specific immunotherapies, we have combined ground-breaking research with cutting-edge technologies to develop therapeutics for cancer and beyond. Our broad and synergistic suite of platforms, which include mRNA therapeutics, engineered cell therapies, antibodies and small molecule immunomodulators have been optimized for distinct modes of action, high precision targeting, high potency and efficacy. We are also developing … Type: | 38 | 17 | 8 | 4,420 |
 | AQEMIA Scale Drug Discovery with Quantum-inspired Physics and AI Aqemia is a pharmatech company using quantum physics and artificial intelligence to transform the drug discovery process. With a unique proprietary technology that preclude the use of experimental data, our pipeline scales the drug discovery process at an unprecedented pace, generating an exhaustive number of new drug candidates. We are hiring! Check our career website: https://jobs.lever.co/aqemia.com Blog Posts on: https://medium.com/aqemia drug discovery, in silico drug discovery, Pharmaceutical R&D, Artificial intelligence, HPC developer, drug hunting, software developer, quantum, and drug design Tags: FrenchTech2030 Type: | 28 | 17 | 16 | 59 |
 | Healshape A regenerative medecine company Healshape is a regenerative medecine project. We aim at developing breast regeneration solutions by 3D bioprinting for women who had mastectomy following breast cancer. Biotechnology, Regenerative medecine, Médecine régénérative, Reconstruction mammaire, Cancer du sein, Breast cancer, Breast regeneration, Breast reconstruction, 3D bioprinting, Tissue engineering, Biologie cellulaire, Impression 3D, Funds raising, and Tissue engineered products Type: | 19 | 17 | 12 | 20 |
 | BioLabs Premier network of co-working spaces for life science startups BioLabs are the premier co-working spaces for life science startups- unique places where you can test, develop and grow your game-changing ideas. As entrepreneurs and investors ourselves, we have first-hand experience with the pain-points biotech start-ups face. Our goal is to change how scientific entrepreneurs do business by building an ecosystem that empowers bioinnovators to grow quickly, while maximizing capital efficiency. coworking, biotech, and pharmaceutical Type: | 40 | 18 | 30 | 123 |
 | MYCOPHYTO [Automatic translation follows] Cultivate balance through Nature www.mycophyto.fr MYCOPHYTO provides concrete solutions for regenerative agriculture. The company, created in 2017, develops unique biological soil regeneration solutions to reduce water and chemical fertilizer inputs (up to 20% reduction in water and synthetic fertilizers) thanks to optimization of associations between plants and mycorrhizal fungi adapted to each territory and each culture. Taking care of our soils and making them resilient means ensuring the sustainability of our food! In an unstable geopolitical context where food sovereignty is a priority, working on fertilizer decarbonization strategies is a necessity. Thanks to unique know-how based on … Tags: FrenchTech2030 Type: | 58 | 18 | 42 | 34 |
 | Woodoo Augmented wood / Decarbonized materials for a new industrial revolution. Woodoo Augmented wood unlock a new industrial age and pave the way to a net-zero world. How? By transforming wood at the molecular scale, turning it into sustainable high-performance material alternatives to steel, glass, leather, plastics, without sacrificing our planet's health. Woodoo doesn't contribute to the already threatened noble wood species or deforestation - quite the opposite. Woodoo gives a new lease of life to substandard and damaged wood species while tapping into a plentiful and 100% renewable resource. Using this dieback wood, we create biomaterials with improved technical characteristics, … Tags: FrenchTech2030 Type: | 57 | 19 | 45 | 44 |
 | AFYREN Biotech company producing biobased organic acids and derivatives via non-food biomass fermentation 🌿 AFYREN is a pioneering biotech company, developing innovative solutions for the production of high value-added biobased compounds. Our purpose is to “enable low-carbon, circular industry by providing biobased solutions built with our partners to benefit the environment”. Our Technology is based on a biomimetic fermentation process patented worldwide through 10 patent families 🔬 Our production model: AFYREN NEOXY, AFYREN’s first plant is a unique, low-carbon, zero-waste biorefinery that produces 7 100% biobased acids. It is located in Carling Saint-Avold (Grand-Est region, France) a strategic location set in … Type: | 70 | 21 | 54 | 112 |
 | Innovafeed Climate change is the challenge of our generation. As innovators, we believe disruptive technology can bring performant solutions to the most dire challenges we face as a society. As we seek a more respectful way of living on our planet, nature itself has much to offer and teach us, starting with feeding the world of tomorrow with better nutrients - for animals, people and our planet - through insects. At Innovafeed, we are committed to inventing efficient technologies that reproduce Nature's processes on a large scale. By building a circular and zero waste agri-food chain replicating insect's role in nature, … Tags: FrenchTech120 FrenchTech2030 Type: | 63 | 22 | 51 | 312 |
 | Inserm Transfert Votre partenaire en valorisation spécialisé dans le transfert de technologies en santé humaine et sciences de la vie Inserm Transfert is the Inserm subsidiary dedicated to value creation and technology transfert in lifescience and human health. Inserm Transfert, the private subsidiary of the French National Institute of the Health and Medical Research (Inserm), is responsible for value creation of Inserm innovations in human health and promotes long-term technology transfers in line with international best practices. Inserm Transfert SA was founded in 2000, and manages, under a Public Service Management Contract (Délégation de Service Public), the entire promotion and transfer of … Type: | 57 | 23 | 40 | 121 |
 | TOOPI ORGANICS [Automatic translation follows] TOOPI recycles, transforms and valorizes human urine into products for agriculture and industry. TOOPI ORGANICS collects, transforms and recycles human urine into products for agriculture and industry. A major economic and ecological issue. #urine #circulareconomy #fertilizer biotechnologies, microbiology, fertilizers, biostimulants, agriculture, gardening, distribution, recycling, start-ups, and innovation Tags: FrenchTech2030 Type: | 50 | 25 | 32 | 33 |
 | Glowee Glowee is a biolighting systen without external energy consumption. It uses the natural ability of luminescent bacteria to produce light. Its usage is comparable to a glowing sticker and therefore it can adopt any graphical form and can for example be used on shop windows to give visibility to brands at night. Type: | 51 | 31 | 15 | 10 |
 | Ÿnsect The world leader in insect ingredient production: a natural, healthy and sustainable solution to feed the world. #BCorp Ÿnsect is one of world leader in the production of protein and natural insect fertilizers. Founded in 2011 in Paris, France, by both scientists and environmental activists, Next40 and B Corp-certified, the company processes insects into high-end, high-value ingredients for animals, plants and humans. From its purpose-built state-of-the-art farms, Ÿnsect offers a long-term, sustainable, organic solution to accelerate protein and plant consumption. Ÿnsect uses pioneering proprietary technology covered by more than 430 patents, to produce its mealworms in fully automated vertical farms. … Tags: FrenchTech120 FrenchTech2030 Type: | 95 | 47 | 53 | 292 |
Startup